Clorox: ERP Overhang Eases, Defense Appeal Remains, But Outlook Still Uncertain (NYSE:CLX)
Following my last article on the Clorox Company (NYSE: CLX ), the stock price declined by roughly 11% and underperformed the benchmark. The consumer staples industry is trading at a forward P/E ofDear Reader,I am a Senior Derivatives Expert with over 10 years of experience in the field of Asset Management, specializing in equity analysis and research, macroeconomics, and risk-managed portfolio construction. My professional background covers both institutional and private client asset management, where I hav ...